GFPT1 and epilepsy: Although variability in severity was also present, only one patient, who presented with neonatal onset, developed early loss of ambulation and displayed additional manifestations not previously described in GFPT1-CMS, including epilepsy, psychiatric symptoms, and intellectual disability.